1)日本膵臓学会編:膵癌取扱い規約,第6版,金原出版,2009
2)日本膵臓学会 膵癌診療ガイドライン改訂委員会:科学的根拠に基づく膵癌診療ガイドライン.金原出版,2009
3)Imamura M, Doi R, Imaizumi T, et al:A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery 136:1003-1011, 2004
4)Oettle H, Post S, Neuhaus P, et al:Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer:a randomized controlled trial. JAMA 297:267-277, 2007
5)Nakamura K, Yamaguchi T, Ishihara T, et al:Phase Ⅱ trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer. Br J Cancer 94:1575-1579, 2006
6)Ueno H, Okusaka T, Ikeda M, et al:An early phase Ⅱ study of S-1 in patients with metastatic pancreatic cancer. Oncology 68:171-178, 2005
7)NCCN Clinical Practice Guidelines in Oncology. Pancreatic adenocarcinoma Ver 2 2010(www.nccn.org)